2030 Sales Side effects 
World of DTC Marketing
MAY 16, 2022
Mounjaro, Lilly’s new diabetes drug, is sure to be in high demand initially after launch, but patients should be aware of its side effects. According to Lilly side, the effects include “Mounjaro may cause tumors in the thyroid, including thyroid cancer and Inflammation of the pancreas (pancreatitis).”
World of DTC Marketing
JULY 17, 2022
A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 16, 2022
The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.
European Pharmaceutical Review
OCTOBER 12, 2022
This is promising when side effects such as ARIAs are often detected in magnetic resonance imaging brain scans of patients who are given the antibodies. If the drug is approved, GlobalData estimates that global sales for HMTM will reach $127 million by 2030.
European Pharmaceutical Review
OCTOBER 24, 2024
Nevertheless, both efficiently clear amyloid and have a similar slowing effect on progression of cognitive decline in patients”. However, side effects of these drugs, such as “the development of amyloid-related imaging abnormalities (ARIAs), remains a significant concern”. billion in 2030, respectively.” billion and $2.0
pharmaphorum
SEPTEMBER 30, 2022
GlobalData notes that the side effect could be a barrier for lecanemab use as it will require patient monitoring, but points out that the rates are a “significant improvement” on Aduhelm, which had an ARIA-E rate of 35% of patients taking the approved dose in clinical trials. .”
Celeritas
SEPTEMBER 26, 2022
The QR code payment market is projected to rise to $35 billion by 2030. QR codes were initially reserved for marketing and sales-related functions, but recently they have made quite some headway in the medical field. This will confirm the company name alongside the date of expiry, contents, and possible side effects.
Expert insights. Personalized for you.
218 
Let's personalize your content